N/A
N=69
Micropulse Laser Trabeculoplasty (MLT) Versus Selective Laser Trabeculoplasty (SLT) for Treatment of Open Angle Glaucoma
Open Angle Glaucoma
Bottom Line
View on ClinicalTrials.gov: NCT01956942 ↗Enrolled (actual)
69
Serious AEs
0.0%
Results posted
Jun 2023
Primary outcome: Primary: Intraocular Pressure Reduction — 17.01; 14.29 percentage change
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Micropulse Laser Trabeculoplasty (Device); Selective Laser Trabeculoplasty (Device)
- Age
- Pediatric, Adult, Older Adult
- Sex
- All
- Sponsor
- David Belyea
- Primary completion
- Jul 2017
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Intraocular Pressure Reduction |
17.01; 14.29 | — |
| PRIMARY Intraocular Pressure (IOP) Reduction Comparison Between MLT and SLT |
15.7; 14.35 | — |
| PRIMARY Intraocular Pressure (IOP) Reduction |
37; 36 | — |
| SECONDARY Measurement of Pain/Inflammation by a Pain Scale Post Laser Treatments From Micropulse and Selective Laser Trabeculoplasty. |
1.34; 2.83; 0.89; 2.81 | — |
Summary
The purpose of this study is to evaluate the effectiveness of a new laser (called Micropulse Laser Trabeculoplasty or MLT) in the treatment of glaucoma compared to the conventional laser presently used which is called selective laser trabeculoplasty or SLT. Both lasers (SLT and MLT) are used as standard of care in the treatment of open angle glaucoma.
Eligibility Criteria
Inclusion Criteria
- Patients of any ange age
- Diagnosis of open angle glaucoma who have not had recent changes in their medication regimen.
Exclusion Criteria
- Patients with active neovascularization of the angle, angle closure glaucoma, angle recession, or anterior uveitis
Data sourced from ClinicalTrials.gov (NCT01956942). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.